• Je něco špatně v tomto záznamu ?

Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma

M. Michal, A. Agaimy, AL. Contreras, M. Svajdler, DV. Kazakov, P. Steiner, P. Grossmann, P. Martinek, L. Hadravsky, K. Michalova, P. Svajdler, Z. Szep, M. Michal, JF. Fetsch,

. 2018 ; 42 (11) : 1530-1540. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035130

In our routine and consultative pathology practices, we have repeatedly encountered an unusual subcutaneous fatty tumor with notable anisocytosis, single-cell fat necrosis, and patchy, often mild, adipocytic nuclear atypia. Because of the focal atypia, consultative cases have most often been received with concern for a diagnosis of atypical lipomatous tumor. Similar tumors have been described in small series under the designations "subcutaneous minimally atypical lipomatous tumors" and "anisometric cell lipoma." Sixty-six cases of this tumor type were collected and reviewed. Immunohistochemistry for p53, MDM2, CDK4, Retinoblastoma 1 (RB1) protein, CD34, S100, and CD163 was performed. Cases were tested for MDM2 gene amplification and RB1 gene deletion with fluorescence in situ hybridization (FISH) and for TP53 mutations by Sanger sequencing. Next-generation sequencing analysis using a panel of 271 cancer-related genes, including TP53, RB1, and MDM2, was also carried out. Our patient cohort included 57 male patients, 8 female patients, and 1 patient of unstated sex, who ranged in age from 22 to 87 years (mean: 51.2 y). All tumors were subcutaneous, with most examples occurring on the upper back, shoulders, or posterior neck (86.4%). Ten patients had multiple (2 to 5) lipomatous tumors, and the histology was confirmed to be similar in the different sites in 4 of them, including 1 patient who had a retinoblastoma diagnosed at age 1. The tumors were generally well circumscribed. At low magnification, there was notable adipocytic size variation with single-cell fat necrosis in the background associated with reactive histiocytes. Adipocytic nuclear atypia was typically patchy and characterized by chromatin coarsening, nuclear enlargement, and focal binucleation or multinucleation. Focal Lochkern change was frequent. In most instances, the degree of atypia was judged to be mild, but in 3 instances, it was more pronounced. Spindle cells were sparse or absent, and when present, cytologically bland. Thick ropy collagen bundles were absent. In all cases, p53 immunoexpression was noted (range: 2% to 20% of adipocytic nuclei), characteristically highlighting the most atypical cells. Twenty of 50 cases had MDM2 immunoreactivity, usually in <1% of the neoplastic cells, but in 4 cases, up to 10% of the cells were positive. Of 32 cases tested, 22 showed a near total loss of RB1 immunoexpression, and the remainder showed partial loss. Three of 13 cases showed RB1 gene deletion in >45% of the cells by FISH (our threshold value for reporting a positive result) with an additional 3 cases being very close to the required cutoff value. MDM2 gene amplification was absent in all 60 cases tested, including those with the greatest MDM2 immunoexpression and most pronounced atypia. All 5 tested cases showed no TP53 mutation with Sanger sequencing. Because of material quality issues, next-generation sequencing analysis could be performed in only 3 cases, and this did not reveal any recurrent mutations. All tumors were managed by simple local excision. Follow-up was available for 47 patients (range: 1 to 192 mo; mean: 27 mo) and revealed 2 local recurrences and no metastases. Dysplastic lipoma is a distinctive atypical fatty tumor variant that has p53 overexpression and RB1 gene abnormalities and lacks MDM2 gene amplification by FISH. These tumors have a strong male predominance and a notable tendency to involve the subcutaneous tissue of the shoulders, upper back and posterior neck. Multifocality is frequent (18.9% of patients with follow-up information), and there is a rare association with retinoblastoma. This tumor warrants separation from ordinary lipoma with fat necrosis, fat-rich spindle cell lipoma and the conventional form of atypical lipomatous tumor that features MDM2 gene amplification.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035130
003      
CZ-PrNML
005      
20191008095801.0
007      
ta
008      
191007s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/PAS.0000000000001129 $2 doi
035    __
$a (PubMed)30001242
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Michal, Michael $u Department of Pathology. Biomedical Center, Faculty of Medicine in Pilsen, Charles University. Bioptical Laboratory Ltd, Pilsen.
245    10
$a Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma / $c M. Michal, A. Agaimy, AL. Contreras, M. Svajdler, DV. Kazakov, P. Steiner, P. Grossmann, P. Martinek, L. Hadravsky, K. Michalova, P. Svajdler, Z. Szep, M. Michal, JF. Fetsch,
520    9_
$a In our routine and consultative pathology practices, we have repeatedly encountered an unusual subcutaneous fatty tumor with notable anisocytosis, single-cell fat necrosis, and patchy, often mild, adipocytic nuclear atypia. Because of the focal atypia, consultative cases have most often been received with concern for a diagnosis of atypical lipomatous tumor. Similar tumors have been described in small series under the designations "subcutaneous minimally atypical lipomatous tumors" and "anisometric cell lipoma." Sixty-six cases of this tumor type were collected and reviewed. Immunohistochemistry for p53, MDM2, CDK4, Retinoblastoma 1 (RB1) protein, CD34, S100, and CD163 was performed. Cases were tested for MDM2 gene amplification and RB1 gene deletion with fluorescence in situ hybridization (FISH) and for TP53 mutations by Sanger sequencing. Next-generation sequencing analysis using a panel of 271 cancer-related genes, including TP53, RB1, and MDM2, was also carried out. Our patient cohort included 57 male patients, 8 female patients, and 1 patient of unstated sex, who ranged in age from 22 to 87 years (mean: 51.2 y). All tumors were subcutaneous, with most examples occurring on the upper back, shoulders, or posterior neck (86.4%). Ten patients had multiple (2 to 5) lipomatous tumors, and the histology was confirmed to be similar in the different sites in 4 of them, including 1 patient who had a retinoblastoma diagnosed at age 1. The tumors were generally well circumscribed. At low magnification, there was notable adipocytic size variation with single-cell fat necrosis in the background associated with reactive histiocytes. Adipocytic nuclear atypia was typically patchy and characterized by chromatin coarsening, nuclear enlargement, and focal binucleation or multinucleation. Focal Lochkern change was frequent. In most instances, the degree of atypia was judged to be mild, but in 3 instances, it was more pronounced. Spindle cells were sparse or absent, and when present, cytologically bland. Thick ropy collagen bundles were absent. In all cases, p53 immunoexpression was noted (range: 2% to 20% of adipocytic nuclei), characteristically highlighting the most atypical cells. Twenty of 50 cases had MDM2 immunoreactivity, usually in <1% of the neoplastic cells, but in 4 cases, up to 10% of the cells were positive. Of 32 cases tested, 22 showed a near total loss of RB1 immunoexpression, and the remainder showed partial loss. Three of 13 cases showed RB1 gene deletion in >45% of the cells by FISH (our threshold value for reporting a positive result) with an additional 3 cases being very close to the required cutoff value. MDM2 gene amplification was absent in all 60 cases tested, including those with the greatest MDM2 immunoexpression and most pronounced atypia. All 5 tested cases showed no TP53 mutation with Sanger sequencing. Because of material quality issues, next-generation sequencing analysis could be performed in only 3 cases, and this did not reveal any recurrent mutations. All tumors were managed by simple local excision. Follow-up was available for 47 patients (range: 1 to 192 mo; mean: 27 mo) and revealed 2 local recurrences and no metastases. Dysplastic lipoma is a distinctive atypical fatty tumor variant that has p53 overexpression and RB1 gene abnormalities and lacks MDM2 gene amplification by FISH. These tumors have a strong male predominance and a notable tendency to involve the subcutaneous tissue of the shoulders, upper back and posterior neck. Multifocality is frequent (18.9% of patients with follow-up information), and there is a rare association with retinoblastoma. This tumor warrants separation from ordinary lipoma with fat necrosis, fat-rich spindle cell lipoma and the conventional form of atypical lipomatous tumor that features MDM2 gene amplification.
650    12
$a tukové buňky $x chemie $x patologie $7 D017667
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a nádorové biomarkery $x analýza $x genetika $7 D014408
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a tuková nekróza $7 D005218
650    _2
$a ženské pohlaví $7 D005260
650    12
$a amplifikace genu $7 D005784
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    12
$a hybridizace in situ fluorescenční $7 D017404
650    12
$a liposarkom $x chemie $x genetika $x patologie $7 D008080
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    12
$a mnohočetné primární nádory $x chemie $x genetika $x patologie $7 D009378
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a protoonkogenní proteiny c-mdm2 $x genetika $7 D051736
650    12
$a retinoblastom $x chemie $x genetika $x patologie $7 D012175
650    _2
$a vazebné proteiny retinoblastomu $x genetika $7 D056286
650    _2
$a retrospektivní studie $7 D012189
650    12
$a nádorový supresorový protein p53 $x analýza $x genetika $7 D016159
650    _2
$a ubikvitinligasy $x genetika $7 D044767
650    _2
$a upregulace $7 D015854
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Agaimy, Abbas $u Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany.
700    1_
$a Contreras, Alejandro Luiña $u The Joint Pathology Center, Silver Spring, MD.
700    1_
$a Svajdler, Marian $u Department of Pathology. Bioptical Laboratory Ltd, Pilsen.
700    1_
$a Kazakov, Dmitry V $u Department of Pathology. Bioptical Laboratory Ltd, Pilsen.
700    1_
$a Steiner, Petr $u Department of Pathology. Bioptical Laboratory Ltd, Pilsen.
700    1_
$a Grossmann, Petr $u Department of Pathology. Bioptical Laboratory Ltd, Pilsen.
700    1_
$a Martinek, Petr $u Department of Pathology. Bioptical Laboratory Ltd, Pilsen.
700    1_
$a Hadravsky, Ladislav $u Department of Pathology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Michalova, Kvetoslava $u Department of Pathology. Bioptical Laboratory Ltd, Pilsen.
700    1_
$a Svajdler, Peter $u Department of Pathology, Louis Pasteur University Hospital, Kosice.
700    1_
$a Szep, Zoltan $u Cytopathos Ltd, Bratislava, Slovakia.
700    1_
$a Michal, Michal $u Department of Pathology. Bioptical Laboratory Ltd, Pilsen.
700    1_
$a Fetsch, John F $u The Joint Pathology Center, Silver Spring, MD.
773    0_
$w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 42, č. 11 (2018), s. 1530-1540
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30001242 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191008100217 $b ABA008
999    __
$a ok $b bmc $g 1451790 $s 1073680
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 42 $c 11 $d 1530-1540 $e - $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...